FOXO TECHNOLOGIES INC. (FOXO)
Sector: Services-Commercial Physical & Biological Research
Industry: Medical - Care Facilities
FOXO Technologies Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 11, 2026 | 0.1688 | 0.1688 | 0.1688 | 0.1688 | 614 |
| Nov 9, 2026 | 0.0899 | 0.1900 | 0.0899 | 0.1900 | 277 |
| Nov 6, 2026 | 0.1000 | 0.1000 | 0.1000 | 0.1000 | 1,004 |
| Nov 5, 2026 | 0.1000 | 0.1000 | 0.1000 | 0.1000 | 364 |
| Nov 3, 2026 | 0.0900 | 0.1200 | 0.0900 | 0.1100 | 8,653 |
| Nov 2, 2026 | 0.1850 | 0.1850 | 0.1850 | 0.1850 | 2,505 |
| Oct 30, 2026 | 0.0612 | 0.1000 | 0.0612 | 0.1000 | 44,078 |
| Oct 29, 2026 | 0.0600 | 0.0600 | 0.0600 | 0.0600 | 502 |
| Oct 28, 2026 | 0.0900 | 0.0900 | 0.0900 | 0.0900 | 8,003 |
| Oct 27, 2026 | 0.1000 | 0.1050 | 0.1000 | 0.1000 | 15,437 |
| Oct 26, 2026 | 0.1020 | 0.1050 | 0.1000 | 0.1000 | 9,030 |
| Oct 23, 2026 | 0.1000 | 0.1000 | 0.1000 | 0.1000 | 14,831 |
| Oct 21, 2026 | 0.1100 | 0.1100 | 0.1000 | 0.1000 | 12,664 |
| Oct 20, 2026 | 0.1190 | 0.1300 | 0.1190 | 0.1300 | 10,047 |
| Oct 19, 2026 | 0.1000 | 0.1000 | 0.1000 | 0.1000 | 2,483 |
| Oct 14, 2026 | 0.1000 | 0.1100 | 0.1000 | 0.1100 | 10,637 |
| Oct 12, 2026 | 0.1000 | 0.1078 | 0.1000 | 0.1078 | 2,911 |
| Oct 9, 2026 | 0.1320 | 0.1320 | 0.1000 | 0.1032 | 6,483 |
| Oct 8, 2026 | 0.1111 | 0.1248 | 0.1111 | 0.1248 | 1,838 |
| Oct 7, 2026 | 0.1279 | 0.1279 | 0.1279 | 0.1279 | 308 |
| Name | Shares | % | Source |
|---|---|---|---|
PEAK6 Capital Management LLC · joint filing· may incl. warrants· filed Nov 2026 | 98.1K | 5.9% | 13G |
SABBY MANAGEMENT, LLC · may incl. warrants· filed Jan 2026 | 83.1K | 5.0% | 13G |
Rennova Health, Inc. · may incl. warrants· stale · filed Sep 2024 | 17 | 0.0% | 13D |
CLEARTHINK CAPITAL PARTNERS, LLC EIN 88-345-9534 · may incl. warrants· stale · filed Dec 2023 | 10 | 0.0% | 13G |
FOXO Technologies Inc. operates as a technology platform company primarily focused on translating longevity science into practical applications for the life insurance sector.
The firm is actively creating products and services that integrate scientific understanding of longevity with life insurance offerings. The dual objectives of these innovations are to encourage greater consumer involvement in their health and wellness, and to streamline the often-complex insurance underwriting process for customers. Among its key offerings is FOXO Labs, a service-oriented platform that enhances the customer underwriting experience by incorporating saliva-based epigenetic biomarkers into expedited underwriting procedures.
Additionally, the company provides FOXO Life, an insurance products platform. This platform offers a combination of FOXO's own unique life insurance products and policies from third-party carriers, all designed to bundle longevity science with life insurance. FOXO Technologies Inc. was established in 2019 and is headquartered in Minneapolis, Minnesota.
No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.
30d Avg
8.70K
60d Avg
7.29K
90d Avg
8.02K
Signal8's dilution snapshot of FOXO as of Sep 30, 2026 records 3 outstanding warrant series and a PIPE closed Mar 2, 2026, from SEC filings. FOXO Technologies Inc. (OTC: FOXO) traded at $0.1688 on Nov 11, 2026, down 11.16% from the previous close of $0.1900. 52-week range: $0.0030 to $1.20. The company is in the Healthcare sector (Medical - Healthcare Information Services).